cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
Unternehmens-codeYCBD
Name des UnternehmenscbdMD Inc
IPO-datumNov 17, 2017
Gegründet am2015
CEOMr. T. Ronan Kennedy
Anzahl der mitarbeiter42
WertpapierartOrdinary Share
GeschäftsjahresendeNov 17
Addresse8845 Red Oak Blvd
StadtCHARLOTTE
BörseNYSE American Consolidated
LandUnited States of America
Postleitzahl28217-5593
Telefon17044453060
Websitehttps://www.cbdmd.com/
Unternehmens-codeYCBD
IPO-datumNov 17, 2017
Gegründet am2015
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten